Enliven Therapeutics
ELVN
#5303
Rank
โ‚ฌ1.11 B
Marketcap
22,75ย โ‚ฌ
Share price
-2.62%
Change (1 day)
111.83%
Change (1 year)

Earnings for Enliven Therapeutics (ELVN)

Earnings in 2024 (TTM): -โ‚ฌ91.81 Million

According to Enliven Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ80.01 Million a decrease over its 2022 earnings that were of -โ‚ฌ37.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enliven Therapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ91.81 Million14.75%
2023 -โ‚ฌ80.01 Million115.33%
2022 -โ‚ฌ37.16 Million